Growth Metrics

Zymeworks (ZYME) Depreciation and Depletion (2022 - 2026)

Zymeworks recorded quarterly Depreciation and Depletion of $963000.0 in Q1 2026, up 7.24% quarter-over-quarter from $898000.0 in Q4 2025, and down 1.83% year-over-year from $981000.0 in Q1 2025.

Zymeworks' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $963000.0 for Q1 2026.

  • In Q1 2026, Depreciation and Depletion fell 1.83% year-over-year to $963000.0; the TTM figure through Mar 2026 stood at $3.7 million (down 11.12% YoY), while the FY2025 annual figure was $3.7 million, down 12.39% from the prior year.
  • Depreciation and Depletion came in at $963000.0 for Q1 2026 at Zymeworks, up from $898000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $2.4 million in Q3 2023 to a low of $885000.0 in Q2 2025.
  • A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Depreciation and Depletion.
  • Across the five-year window, Depreciation and Depletion jumped 73.36% in 2023 and plunged 56.89% in 2024, its largest moves.
  • Zymeworks' Depreciation and Depletion stood at $1.2 million in 2022, then soared by 33.33% to $1.5 million in 2023, then plunged by 35.09% to $997000.0 in 2024, then declined by 9.93% to $898000.0 in 2025, then rose by 7.24% to $963000.0 in 2026.
  • According to Business Quant data, Depreciation and Depletion over the past three periods registered $963000.0, $898000.0, and $905000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Zymeworks 1.84 Bn 1.47 Bn - 963,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 963,000.00
Mar 31, 2026 963,000.00
Dec 31, 2025 898,000.00
Dec 31, 2025 898,000.00
Sep 30, 2025 905,000.00
Sep 30, 2025 905,000.00
Jun 30, 2025 885,000.00
Jun 30, 2025 885,000.00
Mar 31, 2025 981,000.00
Mar 31, 2025 981,000.00
Dec 31, 2024 997,000.00
Dec 31, 2024 997,000.00
Sep 30, 2024 1.04 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.10 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 1.06 Mn
Mar 31, 2024 1.06 Mn
Dec 31, 2023 1.54 Mn
Dec 31, 2023 1.54 Mn
Sep 30, 2023 2.40 Mn
Sep 30, 2023 2.40 Mn
Jun 30, 2023 1.94 Mn
Jun 30, 2023 1.94 Mn
Mar 31, 2023 1.58 Mn
Mar 31, 2023 1.58 Mn
Dec 31, 2022 1.15 Mn
Dec 31, 2022 1.15 Mn
Sep 30, 2022 1.39 Mn
Sep 30, 2022 1.39 Mn
Jun 30, 2022 1.37 Mn
Jun 30, 2022 1.37 Mn
Mar 31, 2022 2.31 Mn
Mar 31, 2022 2.31 Mn